Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone and Quetiapine vs Placebo in Acute Schizophrenia or Schizoaffective Disorder
NCT00061802Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Johnson & Johnson. Started Jun 2003; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00061802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061802.